Valentina Caldiera

Dr. Valentina Caldiera

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Investigative Radiology
Verified
Journal Article
Closed access
AEAnastassia Esseridou
Anastassia Esseridou
GLGiovanni Di Leo
Giovanni Di Leo
LSLuca Maria Sconfienza
Luca Maria Sconfienza
VCValentina Caldiera
Valentina Caldiera
FRFrancesco Raspagliesi
Francesco Raspagliesi
FSFrancesco Sardanelli
Francesco Sardanelli
To assess the clinical feasibility of 3-dimensional (3D) proton magnetic resonance spectroscopy (MRS) of ovarian masses at 1.5 T. We prospectively evaluated 16 patients with 23 ovarian masses using contrast-enhanced magnetic resonance imaging and 3D chemical shift imaging MRS (time of reception/time of echo = 700/135 ms, number of excitations = 6, interpolated voxel = 5 × 5 × 5 mm(3), water and fat suppression). Spectral editing consisted of water reference, filtering, zero-filling, Fourier transformation, frequency shift, automatic baseline and phase correction, and curve fitting. The volume of interest was placed to encompass both solid and cystic tumor components as well as apparently healthy pelvic tissues. The presence of a choline peak at 3.14 to 3.34 ppm was considered as a marker of malignancy. All patients underwent surgery and histopathological evaluation. Of 23 masses, 19 were malignant and the remaining 4 benign lesions were a fibrothecoma, an endometriosis, a cyst, and a cystadenofibroma. A choline peak was detected in 17/19 malignant tumors (sensitivity 89%), absent in 2 G1 tumors. It was visible in 16 solid components of 19 malignant tumors (in one of them, a choline peak was detected only in the cystic component, in 6 in both solid and cystic components). The choline peak was absent in 20/21 apparently healthy pelvic tissues, with a very low choline peak being detected in one intraperitoneal fluid collection with malignant cells at cytologic analysis; 3/4 benign tumors showed a choline peak (overall specificity 21/25 = 84%). A significant difference between the mean choline peak integral detected within the solid component and that within the cystic component was observed (P = 0.002). No correlation between the choline peak integral and the tumor size was found (r = 0.120, P = 0.615). 3D MRS of ovarian masses is clinically feasible at 1.5 T. This opens new research strategies for early diagnosis of ovarian cancer.

18 January 2025 in Movement Disorders
Verified
Journal Article
Open access
ABArianna Braccia
Arianna Braccia
NANico Golfrè Andreasi
Nico Golfrè Andreasi
FGfrancesco ghielmetti
francesco ghielmetti
DADomenico Aquino
Domenico Aquino
ASAnna Paola Savoldi
Anna Paola Savoldi
RERoberto Eleopra
Roberto Eleopra
Background: Magnetic resonance–guided focused ultrasound (MRgFUS) thalamotomy of ventral intermediate (Vim) nucleus is useful to treat drug‐resistant tremor‐dominant Parkinson's disease (TdPD), but tremor relapse may occur. Predictors of relapse have been poorly investigated so far.Objective: The aim of this study is to evaluate the role of clinico‐demographic, procedural, and neuroradiological variables in determining clinical response, relapse, and adverse events (AEs) in TdPD after MRgFUS Vim‐thalamotomy.Methods: Fifty‐two TdPD patients who consecutively underwent unilateral MRgFUS Vim‐thalamotomy were prospectively evaluated at baseline and after 24 hours, 1 month, 6 months, and 12 months using MDS‐UPDRS‐III in off and on medication conditions. AEs were collected at each evaluation. Lesion volume was calculated at 24‐hour magnetic resonance imaging (MRI). Patients with tremor improvement 30% at 24 hours. Tremor relapse occurred in 12 patients (23%), exclusively during the first month after thalamotomy. Relapse was associated with younger age (P = 0.030) and smaller lesion volume (P = 0.030). At 1 month, 22 patients (42%) had AEs; at 6 and 12 months, AEs persisted in 19% and 6% of cases. AEs at 6 months were associated with larger lesions (P = 0.018). All AEs were mild.Conclusions: MRgFUS Vim‐thalamotomy is effective in treating tremor in TdPD. Relapse is associated with younger age and smaller lesion volume, but larger lesions make AEs more likely to persist. We suggest that a lesion volume between 145 and 220 mm3 on T1‐weighted MRI may be the therapeutic window that ensures tremor control without long‐lasting AEs. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

10 November 2023 in Movement Disorders Clinical Practice
Verified
Journal Article
Open access
NANico Golfrè Andreasi
Nico Golfrè Andreasi
ABArianna Braccia
Arianna Braccia
VLVincenzo Levi
Vincenzo Levi
SRSara Rinaldo
Sara Rinaldo
FGfrancesco ghielmetti
francesco ghielmetti
RERoberto Eleopra
Roberto Eleopra
Background: Magnetic resonance‐guided focused ultrasound (MRgFUS) thalamotomy is increasingly used to treat drug‐resistant essential tremor (ET). Data on MRgFUS thalamotomy in dystonic tremor (DT) are anecdotal.Objectives: To investigate efficacy, safety, and differences in target coordinates of MRgFUS thalamotomy in DT versus ET.Methods: Ten patients with DT and 35 with ET who consecutively underwent MRgFUS thalamotomy were followed for 12 months. Although in both groups the initial surgical planning coordinates corresponded to the ventralis intermediate (Vim), the final target could be modified intraoperatively based on clinical response.Results: Tremor significantly improved in both groups. The thalamic lesion was significantly more anterior in DT than ET. Considering both ET and DT groups, the more anterior the lesion, the lower the odds ratio for adverse events.Conclusions: MRgFUS thalamotomy is safe and effective in DT and ET. Compared to classical Vim coordinates used for ET, more anterior targeting should be considered for DT.

31 March 2010 in Journal of Ultrasound
Verified
Journal Article
Closed access
LSLuca Maria Sconfienza
Luca Maria Sconfienza
FLF. Lacelli
F. Lacelli
VCValentina Caldiera
Valentina Caldiera
NPN. Perrone
N. Perrone
FPF. Piscopo
F. Piscopo
GSG. Serafini
G. Serafini

26 August 2016 in European Radiology
Verified
Journal Article
Closed access
PDF file
GFGiuseppe Faragò
Giuseppe Faragò
VCValentina Caldiera
Valentina Caldiera
CAC. Antozzi
C. Antozzi
ABA. Bellino
A. Bellino
AIA. Innocenti
A. Innocenti
ECElisa Francesca Maria Ciceri
Elisa Francesca Maria Ciceri

13 January 2015 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
GFGiuseppe Faragò
Giuseppe Faragò
VCValentina Caldiera
Valentina Caldiera
GTGiovanni Tempra
Giovanni Tempra
ECElisa Francesca Maria Ciceri
Elisa Francesca Maria Ciceri
In recent years there has been a progressive increase in interventional neuroradiology procedures, partially due to improvements in devices, but also to the simultaneous development of technologies and radiological images. Cone beam CT (Dyna-CT; Siemens) is a method recently used to obtain pseudo CT images from digital subtraction angiography (DSA) with a flat panel detector. Using dedicated software, it is then possible to merge Dyna-CT images with images from a different source. We report here the usefulness of advanced DSA techniques (Syngo-Dyna CT, three-dimensional DSA iPilot) for the treatment of an intracranial aneurysm with a flow diverter device. Merging MR and Dyna-CT images at the end of the procedure proved to be a simple and rapid additional method of verifying the success of the intervention.